WAVE Life Sciences Ltd banner

WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 14.08 USD 2.4% Market Closed
Market Cap: $2.6B

Relative Value

The Relative Value of one WVE stock under the Base Case scenario is hidden USD. Compared to the current market price of 14.08 USD, WAVE Life Sciences Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WVE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

WVE Competitors Multiples
WAVE Life Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SG
WAVE Life Sciences Ltd
NASDAQ:WVE
2.6B USD 61.8 -12.9 -9.6 -9.5
US
Eli Lilly and Co
NYSE:LLY
944.6B USD 14.5 45.8 30.9 32.9
US
Johnson & Johnson
NYSE:JNJ
585.1B USD 6.2 21.8 15.2 18.6
CH
Roche Holding AG
SIX:ROG
253.8B CHF 4.1 19.8 11.7 13.2
UK
AstraZeneca PLC
LSE:AZN
223.4B GBP 5.1 29.4 16.3 22.9
CH
Novartis AG
SIX:NOVN
232.6B CHF 5.3 21.5 13.3 17.1
US
Merck & Co Inc
NYSE:MRK
287.6B USD 4.4 15.8 9.8 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 10.9 8 9.4
US
Pfizer Inc
NYSE:PFE
155.2B USD 2.5 20 7.7 10.2
US
Bristol-Myers Squibb Co
NYSE:BMY
120.7B USD 2.5 17.1 7.2 8.9
P/E Multiple
Earnings Growth PEG
SG
WAVE Life Sciences Ltd
NASDAQ:WVE
Average P/E: 22.4
Negative Multiple: -12.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
45.8
32%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.8
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.8
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.4
26%
1.1
CH
Novartis AG
SIX:NOVN
21.5
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.8
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
US
Pfizer Inc
NYSE:PFE
20
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SG
WAVE Life Sciences Ltd
NASDAQ:WVE
Average EV/EBITDA: 46.5
Negative Multiple: -9.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.9
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
11.7
6%
2
UK
AstraZeneca PLC
LSE:AZN
16.3
13%
1.3
CH
Novartis AG
SIX:NOVN
13.3
5%
2.7
US
Merck & Co Inc
NYSE:MRK
9.8
3%
3.3
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8
1%
8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SG
WAVE Life Sciences Ltd
NASDAQ:WVE
Average EV/EBIT: 101
Negative Multiple: -9.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.9
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
18.6
7%
2.7
CH
Roche Holding AG
SIX:ROG
13.2
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
22.9
21%
1.1
CH
Novartis AG
SIX:NOVN
17.1
9%
1.9
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.4
3%
3.1
US
Pfizer Inc
NYSE:PFE
10.2
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.9
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett